The pathological basis of thymoma-associated myasthenia gravis.
Müller-Hermelink
H K
HK
Institute of Pathology, University of Würzburg, Germany.
Marx
A
A
Geuder
K
K
Kirchner
T
T
D000911:Antibodies, Monoclonal / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology; D003429:Cross Reactions; D004848:Epithelium / Q000378:metabolism; D000939:Epitopes; D006801:Humans; D007473:Ion Channels / Q000378:metabolism; D009124:Muscle Proteins / Q000276:immunology; D009157:Myasthenia Gravis / Q000150:complications / Q000473:pathology*; D011978:Receptors, Nicotinic / Q000276:immunology / Q000378:metabolism; D013945:Thymoma / Q000150:complications* / Q000276:immunology / Q000473:pathology; D013953:Thymus Neoplasms / Q000150:complications* / Q000276:immunology / Q000473:pathology
D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D000939:Epitopes; D007473:Ion Channels; D009124:Muscle Proteins; D011978:Receptors, Nicotinic